Allscripts Appoints Vice President and Managing Director, EMEA

AllscriptsAllscripts (NASDAQ: MDRX) has appointed a new leader for its business in the UK while strengthening its focus on Europe, the Middle East and Africa. Richard Strong, who was Vice President, International Services, is taking up the new role of vice president and managing director, EMEA.

Strong said his first priorities for the coming year would be to increase the number of NHS trusts signed-up to deploy the Sunrise electronic patient record and to raise awareness of the capabilities of its dbMotion population health management solution.

He said he would also be looking to bring new clinical and departmental systems to the UK, while taking elements of the UK approach to the Middle East, where there is keen interest in population health management, as well as in administrative and clinical systems.

"Allscripts is well-established in the UK and popular with ourcustomers," he said. "I am looking forward to building onthe excellent work we have already achievedwithin the region with the Global Digital Exemplar programme in the UK and with customers that have benefited from our clinical wrap approach."

"I want more people to hear about what Allscripts has delivered at some of the top performing trusts in the United Kingdom, which use dbMotion to share information with GPs and explore population health management. As we develop our strategy for EMEA, I want more organisations to benefit from the solutions that we are already deploying across the UK."

Strong started his career in the NHS in London, where his work as a biomedical scientist drew him into the implementation of laboratory information systems. He went on to work for Siemens Healthcare Systems and then Cerner UK, where he played a key role in the implementation of electronic patient record systems in the capital, before becoming its director of European services.

He also worked in both UK and international roles for Dell, before joining Allscripts in 2016, to help grow its global ambitions.

Alan Fowles, President Allscripts International, said: "The creation of the new role of vice president and managing director, EMEA, shows our commitment to growing Allscripts as a global company."

"Richard's background in the health tech industry, and his deep understanding of the requirements of health and care organisations in the UK, across Europe, and in the Middle East makes him the ideal choice for the role, and we are confident that this will enable more organisations to benefit from Allscripts’ sector-leading solutions, knowledge and experience."

Allscripts' rapid expansion and high levels of customer satisfaction were recognised in a 2018 KLAS performance report on the European electronic record market, which noted that it had gone from one Sunrise customer in 2011 to eight when the report was written.

The company is currently running a clinical wrap campaign to support trusts that want to digitise without the cost and disruption caused by scrapping their existing patient administration systems and other IT investments.

This is in line with the NHS Long Term Plan’s recognition to complete the digitisation of hospitals through an extension of the GDE programme and an accelerated roll-out of EPRs. The plan also gave strong support to the development and deployment of population health management.

Some of the additional products that Allscripts will be bringing to the UK from other regions include Sunrise Surgical Care with iPro Anaesthesia, the Patient Flow with Census Logic hospital status application, and Follow My Health, a patient engagement platform, as well as integrated electronic document management.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...